Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, 2seventy bio's Enterprise Value is MXN6,500.8 Mil.
2seventy bio's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was MXN-1,169.6 Mil. Therefore, 2seventy bio's EV-to-EBIT ratio for today is -5.56.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, 2seventy bio's Enterprise Value is MXN6,500.8 Mil.
2seventy bio's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was MXN-1,038.2 Mil. Therefore, 2seventy bio's EV-to-EBITDA ratio for today is -6.26.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, 2seventy bio's Enterprise Value is MXN6,500.8 Mil.
2seventy bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was MXN961.1 Mil. Therefore, 2seventy bio's EV-to-Revenue ratio for today is 6.76.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, 2seventy bio's Enterprise Value is MXN6,500.8 Mil.
2seventy bio's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was MXN-1,054.7 Mil. Therefore, 2seventy bio's EV-to-FCF ratio for today is -6.16.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
2seventy bio (MEX:TSVT) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
2seventy bio's current Enterprise Value is MXN6,500.8 Mil.
2seventy bio's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-1,169.6 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
2seventy bio's current Enterprise Value is MXN6,500.8 Mil.
2seventy bio's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-1,038.2 Mil.
2seventy bio's current Enterprise Value is MXN6,500.8 Mil.
2seventy bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN961.1 Mil.
2seventy bio's current Enterprise Value is MXN6,500.8 Mil.
2seventy bio's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-1,052.9 Mil.
2seventy bio's current Enterprise Value is MXN6,500.8 Mil.
2seventy bio's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-1,054.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
2seventy bio Enterprise Value Related Terms
2seventy bio Enterprise Value Historical Data
* Premium members only.
The historical data trend for 2seventy bio's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:TSVT vs ALMS, TERN, CRVS: Enterprise Value Comparison
For the Biotechnology subindustry, 2seventy bio's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
2seventy bio Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 2seventy bio's Enterprise Value distribution charts can be found below:
* The bar in red indicates where 2seventy bio's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
2seventy bio's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of MXN6,500.8 Mil mean?
2seventy bio (MEX:TSVT) has a Enterprise Value of MXN6,500.8 Mil as of Aug. 25, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on 2seventy bio and its competitors.
Is 2seventy bio's Enterprise Value too high?
2seventy bio's current Enterprise Value is MXN6,500.8 Mil. Overall, 2seventy bio has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does 2seventy bio's Enterprise Value compare to ALMS and TERN?
2seventy bio's Enterprise Value of MXN6,500.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on 2seventy bio and its competitors. 2seventy bio's current Enterprise Value is MXN6,500.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 2seventy bio stock overvalued right now?
2seventy bio (MEX:TSVT) has a current Enterprise Value of MXN6,500.8 Mil. The current Enterprise Value is MXN6,500.8 Mil. 2seventy bio's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For 2seventy bio (MEX:TSVT), the current Enterprise Value is MXN6,500.8 Mil as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.
9GF Score
Get the complete analysis for MEX:TSVT
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TSVT has been successfully added to your 
